4,070 research outputs found
Reverse engineering of drug induced DNA damage response signalling pathway reveals dual outcomes of ATM kinase inhibition
The DNA Damage Response (DDR) pathway represents a signalling mechanism that is activated in eukaryotic cells following DNA damage and comprises of proteins involved in DNA damage detection, DNA repair, cell cycle arrest and apoptosis. This pathway consists of an intricate network of signalling interactions driving the cellular ability to recognise DNA damage and recruit specialised proteins to take decisions between DNA repair or apoptosis. ATM and ATR are central components of the DDR pathway. The activities of these kinases are vital in DNA damage induced phosphorylational induction of DDR substrates. Here, firstly we have experimentally determined DDR signalling network surrounding the ATM/ATR pathway induced following double stranded DNA damage by monitoring and quantifying time dependent inductions of their phosphorylated forms and their key substrates. We next involved an automated inference of unsupervised predictive models of time series data to generate in silico (molecular) interaction maps. We characterized the complex signalling network through system analysis and gradual utilisation of small time series measurements of key substrates through a novel network inference algorithm. Furthermore, we demonstrate an application of an assumption-free reverse engineering of the intricate signalling network of the activated ATM/ATR pathway. We next studied the consequences of such drug induced inductions as well as of time dependent ATM kinase inhibition on cell survival through further biological experiments. Intermediate and temporal modelling outcomes revealed the distinct signaling profile associated with ATM kinase activity and inhibition and explained the underlying signalling mechanism for dual ATM functionality in cytotoxic and cytoprotective pathways
Recommended from our members
The Computational Diet: A Review of Computational Methods Across Diet, Microbiome, and Health.
Food and human health are inextricably linked. As such, revolutionary impacts on health have been derived from advances in the production and distribution of food relating to food safety and fortification with micronutrients. During the past two decades, it has become apparent that the human microbiome has the potential to modulate health, including in ways that may be related to diet and the composition of specific foods. Despite the excitement and potential surrounding this area, the complexity of the gut microbiome, the chemical composition of food, and their interplay in situ remains a daunting task to fully understand. However, recent advances in high-throughput sequencing, metabolomics profiling, compositional analysis of food, and the emergence of electronic health records provide new sources of data that can contribute to addressing this challenge. Computational science will play an essential role in this effort as it will provide the foundation to integrate these data layers and derive insights capable of revealing and understanding the complex interactions between diet, gut microbiome, and health. Here, we review the current knowledge on diet-health-gut microbiota, relevant data sources, bioinformatics tools, machine learning capabilities, as well as the intellectual property and legislative regulatory landscape. We provide guidance on employing machine learning and data analytics, identify gaps in current methods, and describe new scenarios to be unlocked in the next few years in the context of current knowledge
TREEOME: A framework for epigenetic and transcriptomic data integration to explore regulatory interactions controlling transcription
Motivation: Predictive modelling of gene expression is a powerful framework
for the in silico exploration of transcriptional regulatory interactions
through the integration of high-throughput -omics data. A major limitation of
previous approaches is their inability to handle conditional and synergistic
interactions that emerge when collectively analysing genes subject to different
regulatory mechanisms. This limitation reduces overall predictive power and
thus the reliability of downstream biological inference.
Results: We introduce an analytical modelling framework (TREEOME: tree of
models of expression) that integrates epigenetic and transcriptomic data by
separating genes into putative regulatory classes. Current predictive modelling
approaches have found both DNA methylation and histone modification epigenetic
data to provide little or no improvement in accuracy of prediction of
transcript abundance despite, for example, distinct anti-correlation between
mRNA levels and promoter-localised DNA methylation. To improve on this, in
TREEOME we evaluate four possible methods of formulating gene-level DNA
methylation metrics, which provide a foundation for identifying gene-level
methylation events and subsequent differential analysis, whereas most previous
techniques operate at the level of individual CpG dinucleotides. We demonstrate
TREEOME by integrating gene-level DNA methylation (bisulfite-seq) and histone
modification (ChIP-seq) data to accurately predict genome-wide mRNA transcript
abundance (RNA-seq) for H1-hESC and GM12878 cell lines.
Availability: TREEOME is implemented using open-source software and made
available as a pre-configured bootable reference environment. All scripts and
data presented in this study are available online at
http://sourceforge.net/projects/budden2015treeome/.Comment: 14 pages, 6 figure
Supporting the identification of novel fragment-based positive allosteric modulators using a supervised molecular dynamics approach: A retrospective analysis considering the human A2A adenosine receptor as a key example
Structure-driven fragment-based (SDFB) approaches have provided efficient methods for the identification of novel drug candidates. This strategy has been largely applied in discovering several pharmacological ligand classes, including enzyme inhibitors, receptor antagonists and, more recently, also allosteric (positive and negative) modulators. Recently, Siegal and collaborators reported an interesting study, performed on a detergent-solubilized StaR adenosine A2A receptor, describing the existence of both fragment-like negative allosteric modulators (NAMs), and fragment-like positive allosteric modulators (PAMs). From this retrospective study, our results suggest that Supervised Molecular Dynamics (SuMD) simulations can support, on a reasonable time scale, the identification of fragment-like PAMs following their receptor recognition pathways and characterizing the possible allosteric binding sites
A network inference method for large-scale unsupervised identification of novel drug-drug interactions
Characterizing interactions between drugs is important to avoid potentially
harmful combinations, to reduce off-target effects of treatments and to fight
antibiotic resistant pathogens, among others. Here we present a network
inference algorithm to predict uncharacterized drug-drug interactions. Our
algorithm takes, as its only input, sets of previously reported interactions,
and does not require any pharmacological or biochemical information about the
drugs, their targets or their mechanisms of action. Because the models we use
are abstract, our approach can deal with adverse interactions,
synergistic/antagonistic/suppressing interactions, or any other type of drug
interaction. We show that our method is able to accurately predict
interactions, both in exhaustive pairwise interaction data between small sets
of drugs, and in large-scale databases. We also demonstrate that our algorithm
can be used efficiently to discover interactions of new drugs as part of the
drug discovery process
Recommended from our members
SCALE method for single-cell ATAC-seq analysis via latent feature extraction.
Single-cell ATAC-seq (scATAC-seq) profiles the chromatin accessibility landscape at single cell level, thus revealing cell-to-cell variability in gene regulation. However, the high dimensionality and sparsity of scATAC-seq data often complicate the analysis. Here, we introduce a method for analyzing scATAC-seq data, called Single-Cell ATAC-seq analysis via Latent feature Extraction (SCALE). SCALE combines a deep generative framework and a probabilistic Gaussian Mixture Model to learn latent features that accurately characterize scATAC-seq data. We validate SCALE on datasets generated on different platforms with different protocols, and having different overall data qualities. SCALE substantially outperforms the other tools in all aspects of scATAC-seq data analysis, including visualization, clustering, and denoising and imputation. Importantly, SCALE also generates interpretable features that directly link to cell populations, and can potentially reveal batch effects in scATAC-seq experiments
- …